Fibrosis-related biomarkers and large and small vessel disease: The Cardiovascular Health Study

Isha Agarwal, Alice Arnold, Nicole L. Glazer, Eddy Barasch, Luc Djousse, Annette L. Fitzpatrick, John S. Gottdiener, Joachim H. Ix, Richard A. Jensen, Jorge Kizer, Eric B. Rimm, David S. Siscovick, Russell P. Tracy, Tien Y. Wong, Kenneth J. Mukamal

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Objective: Fibrosis has been implicated in a number of pathological, organ-based conditions of the liver, kidney, heart, and lungs. The objective of this study was to determine whether biomarkers of fibrosis are associated with vascular disease in the large and/or small vessels. Methods: We evaluated the associations of two circulating biomarkers of fibrosis, transforming growth factor-β (TGF-β) and procollagen type III N-terminal propeptide (PIIINP), with incident peripheral artery disease (PAD) and subclinical macrovascular (carotid intima-media thickness, flow-mediated vasodilation, ankle-brachial index, retinal vein diameter), and microvascular (retinal artery diameter and retinopathy) disease among older adults in the Cardiovascular Health Study. We measured TGF-β and PIIINP from samples collected in 1996 and ascertained clinical PAD through 2011. Measurements of large and small vessels were collected between 1996 and 1998. Results: After adjustment for sociodemographic, clinical, and biochemical risk factors, TGF-β was associated with incident PAD (hazard ratio [HR]=1.36 per doubling of TGF-β, 95% confidence interval [CI]=1.04, 1.78) and retinal venular diameter (1.63μm per doubling of TGF-β, CI=0.23, 3.02). PIIINP was not associated with incident PAD, but was associated with carotid intima-media thickness (0.102mm per doubling of PIIINP, CI=0.029, 0.174) and impaired brachial artery reactivity (-0.20% change per doubling of PIIINP, CI=-0.39,-0.02). Neither TGF-β nor PIIINP were associated with retinal arteriolar diameter or retinopathy. Conclusions: Serum concentrations of fibrosis-related biomarkers were associated with several measures of large vessel disease, including incident PAD, but not with small vessel disease. Fibrosis may contribute to large vessel atherosclerosis in older adults.

Original languageEnglish (US)
Pages (from-to)539-546
Number of pages8
JournalAtherosclerosis
Volume239
Issue number2
DOIs
StatePublished - Apr 1 2015

Fingerprint

Collagen Type III
Transforming Growth Factors
Peripheral Arterial Disease
Fibrosis
Cardiovascular Diseases
Biomarkers
Health
Confidence Intervals
Carotid Intima-Media Thickness
Retinal Artery
Retinal Vein
Ankle Brachial Index
Brachial Artery
Vascular Diseases
Vasodilation
Atherosclerosis
Kidney
Lung
Liver
Serum

Keywords

  • Atherosclerosis
  • Fibrosis
  • Peripheral artery disease

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Agarwal, I., Arnold, A., Glazer, N. L., Barasch, E., Djousse, L., Fitzpatrick, A. L., ... Mukamal, K. J. (2015). Fibrosis-related biomarkers and large and small vessel disease: The Cardiovascular Health Study. Atherosclerosis, 239(2), 539-546. https://doi.org/10.1016/j.atherosclerosis.2015.02.020

Fibrosis-related biomarkers and large and small vessel disease : The Cardiovascular Health Study. / Agarwal, Isha; Arnold, Alice; Glazer, Nicole L.; Barasch, Eddy; Djousse, Luc; Fitzpatrick, Annette L.; Gottdiener, John S.; Ix, Joachim H.; Jensen, Richard A.; Kizer, Jorge; Rimm, Eric B.; Siscovick, David S.; Tracy, Russell P.; Wong, Tien Y.; Mukamal, Kenneth J.

In: Atherosclerosis, Vol. 239, No. 2, 01.04.2015, p. 539-546.

Research output: Contribution to journalArticle

Agarwal, I, Arnold, A, Glazer, NL, Barasch, E, Djousse, L, Fitzpatrick, AL, Gottdiener, JS, Ix, JH, Jensen, RA, Kizer, J, Rimm, EB, Siscovick, DS, Tracy, RP, Wong, TY & Mukamal, KJ 2015, 'Fibrosis-related biomarkers and large and small vessel disease: The Cardiovascular Health Study', Atherosclerosis, vol. 239, no. 2, pp. 539-546. https://doi.org/10.1016/j.atherosclerosis.2015.02.020
Agarwal, Isha ; Arnold, Alice ; Glazer, Nicole L. ; Barasch, Eddy ; Djousse, Luc ; Fitzpatrick, Annette L. ; Gottdiener, John S. ; Ix, Joachim H. ; Jensen, Richard A. ; Kizer, Jorge ; Rimm, Eric B. ; Siscovick, David S. ; Tracy, Russell P. ; Wong, Tien Y. ; Mukamal, Kenneth J. / Fibrosis-related biomarkers and large and small vessel disease : The Cardiovascular Health Study. In: Atherosclerosis. 2015 ; Vol. 239, No. 2. pp. 539-546.
@article{52f01307125c45e7ac18c96297eb22f9,
title = "Fibrosis-related biomarkers and large and small vessel disease: The Cardiovascular Health Study",
abstract = "Objective: Fibrosis has been implicated in a number of pathological, organ-based conditions of the liver, kidney, heart, and lungs. The objective of this study was to determine whether biomarkers of fibrosis are associated with vascular disease in the large and/or small vessels. Methods: We evaluated the associations of two circulating biomarkers of fibrosis, transforming growth factor-β (TGF-β) and procollagen type III N-terminal propeptide (PIIINP), with incident peripheral artery disease (PAD) and subclinical macrovascular (carotid intima-media thickness, flow-mediated vasodilation, ankle-brachial index, retinal vein diameter), and microvascular (retinal artery diameter and retinopathy) disease among older adults in the Cardiovascular Health Study. We measured TGF-β and PIIINP from samples collected in 1996 and ascertained clinical PAD through 2011. Measurements of large and small vessels were collected between 1996 and 1998. Results: After adjustment for sociodemographic, clinical, and biochemical risk factors, TGF-β was associated with incident PAD (hazard ratio [HR]=1.36 per doubling of TGF-β, 95{\%} confidence interval [CI]=1.04, 1.78) and retinal venular diameter (1.63μm per doubling of TGF-β, CI=0.23, 3.02). PIIINP was not associated with incident PAD, but was associated with carotid intima-media thickness (0.102mm per doubling of PIIINP, CI=0.029, 0.174) and impaired brachial artery reactivity (-0.20{\%} change per doubling of PIIINP, CI=-0.39,-0.02). Neither TGF-β nor PIIINP were associated with retinal arteriolar diameter or retinopathy. Conclusions: Serum concentrations of fibrosis-related biomarkers were associated with several measures of large vessel disease, including incident PAD, but not with small vessel disease. Fibrosis may contribute to large vessel atherosclerosis in older adults.",
keywords = "Atherosclerosis, Fibrosis, Peripheral artery disease",
author = "Isha Agarwal and Alice Arnold and Glazer, {Nicole L.} and Eddy Barasch and Luc Djousse and Fitzpatrick, {Annette L.} and Gottdiener, {John S.} and Ix, {Joachim H.} and Jensen, {Richard A.} and Jorge Kizer and Rimm, {Eric B.} and Siscovick, {David S.} and Tracy, {Russell P.} and Wong, {Tien Y.} and Mukamal, {Kenneth J.}",
year = "2015",
month = "4",
day = "1",
doi = "10.1016/j.atherosclerosis.2015.02.020",
language = "English (US)",
volume = "239",
pages = "539--546",
journal = "Atherosclerosis",
issn = "0021-9150",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Fibrosis-related biomarkers and large and small vessel disease

T2 - The Cardiovascular Health Study

AU - Agarwal, Isha

AU - Arnold, Alice

AU - Glazer, Nicole L.

AU - Barasch, Eddy

AU - Djousse, Luc

AU - Fitzpatrick, Annette L.

AU - Gottdiener, John S.

AU - Ix, Joachim H.

AU - Jensen, Richard A.

AU - Kizer, Jorge

AU - Rimm, Eric B.

AU - Siscovick, David S.

AU - Tracy, Russell P.

AU - Wong, Tien Y.

AU - Mukamal, Kenneth J.

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Objective: Fibrosis has been implicated in a number of pathological, organ-based conditions of the liver, kidney, heart, and lungs. The objective of this study was to determine whether biomarkers of fibrosis are associated with vascular disease in the large and/or small vessels. Methods: We evaluated the associations of two circulating biomarkers of fibrosis, transforming growth factor-β (TGF-β) and procollagen type III N-terminal propeptide (PIIINP), with incident peripheral artery disease (PAD) and subclinical macrovascular (carotid intima-media thickness, flow-mediated vasodilation, ankle-brachial index, retinal vein diameter), and microvascular (retinal artery diameter and retinopathy) disease among older adults in the Cardiovascular Health Study. We measured TGF-β and PIIINP from samples collected in 1996 and ascertained clinical PAD through 2011. Measurements of large and small vessels were collected between 1996 and 1998. Results: After adjustment for sociodemographic, clinical, and biochemical risk factors, TGF-β was associated with incident PAD (hazard ratio [HR]=1.36 per doubling of TGF-β, 95% confidence interval [CI]=1.04, 1.78) and retinal venular diameter (1.63μm per doubling of TGF-β, CI=0.23, 3.02). PIIINP was not associated with incident PAD, but was associated with carotid intima-media thickness (0.102mm per doubling of PIIINP, CI=0.029, 0.174) and impaired brachial artery reactivity (-0.20% change per doubling of PIIINP, CI=-0.39,-0.02). Neither TGF-β nor PIIINP were associated with retinal arteriolar diameter or retinopathy. Conclusions: Serum concentrations of fibrosis-related biomarkers were associated with several measures of large vessel disease, including incident PAD, but not with small vessel disease. Fibrosis may contribute to large vessel atherosclerosis in older adults.

AB - Objective: Fibrosis has been implicated in a number of pathological, organ-based conditions of the liver, kidney, heart, and lungs. The objective of this study was to determine whether biomarkers of fibrosis are associated with vascular disease in the large and/or small vessels. Methods: We evaluated the associations of two circulating biomarkers of fibrosis, transforming growth factor-β (TGF-β) and procollagen type III N-terminal propeptide (PIIINP), with incident peripheral artery disease (PAD) and subclinical macrovascular (carotid intima-media thickness, flow-mediated vasodilation, ankle-brachial index, retinal vein diameter), and microvascular (retinal artery diameter and retinopathy) disease among older adults in the Cardiovascular Health Study. We measured TGF-β and PIIINP from samples collected in 1996 and ascertained clinical PAD through 2011. Measurements of large and small vessels were collected between 1996 and 1998. Results: After adjustment for sociodemographic, clinical, and biochemical risk factors, TGF-β was associated with incident PAD (hazard ratio [HR]=1.36 per doubling of TGF-β, 95% confidence interval [CI]=1.04, 1.78) and retinal venular diameter (1.63μm per doubling of TGF-β, CI=0.23, 3.02). PIIINP was not associated with incident PAD, but was associated with carotid intima-media thickness (0.102mm per doubling of PIIINP, CI=0.029, 0.174) and impaired brachial artery reactivity (-0.20% change per doubling of PIIINP, CI=-0.39,-0.02). Neither TGF-β nor PIIINP were associated with retinal arteriolar diameter or retinopathy. Conclusions: Serum concentrations of fibrosis-related biomarkers were associated with several measures of large vessel disease, including incident PAD, but not with small vessel disease. Fibrosis may contribute to large vessel atherosclerosis in older adults.

KW - Atherosclerosis

KW - Fibrosis

KW - Peripheral artery disease

UR - http://www.scopus.com/inward/record.url?scp=84923353953&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923353953&partnerID=8YFLogxK

U2 - 10.1016/j.atherosclerosis.2015.02.020

DO - 10.1016/j.atherosclerosis.2015.02.020

M3 - Article

C2 - 25725316

AN - SCOPUS:84923353953

VL - 239

SP - 539

EP - 546

JO - Atherosclerosis

JF - Atherosclerosis

SN - 0021-9150

IS - 2

ER -